2020
Multisystem Imaging Manifestations of COVID-19, Part 1: Viral Pathogenesis and Pulmonary and Vascular System Complications
Revzin MV, Raza S, Warshawsky R, D'Agostino C, Srivastava NC, Bader AS, Malhotra A, Patel RD, Chen K, Kyriakakos C, Pellerito JS. Multisystem Imaging Manifestations of COVID-19, Part 1: Viral Pathogenesis and Pulmonary and Vascular System Complications. Radio Graphics 2020, 40: 1574-1599. PMID: 33001783, PMCID: PMC7534458, DOI: 10.1148/rg.2020200149.Peer-Reviewed Educational MaterialsMeSH KeywordsAngiographyAngiotensin-Converting Enzyme 2BetacoronavirusCoronavirus InfectionsCOVID-19Cytokine Release SyndromeDisease ProgressionFibrin Fibrinogen Degradation ProductsHumansInflammationLungPandemicsPeptidyl-Dipeptidase APneumonia, ViralPulmonary ArteryReceptors, VirusRespiratory Distress SyndromeSARS-CoV-2Symptom AssessmentThromboembolismThrombosisThrombotic MicroangiopathiesTomography, X-Ray ComputedUltrasonographyConceptsKey imaging featuresImaging featuresCOVID-19COVID-19-associated deathsPregnancy-related manifestationsCoronavirus disease 2019Effective patient managementWorld Health OrganizationVascular complicationsClinical presentationRelated complicationsImaging manifestationsMultisystemic involvementPathologic manifestationsPatient managementImage-based reviewDisease 2019Online supplemental materialImaging hallmarksCentral vascular systemOrgan systemsRespiratory systemInfectionMusculoskeletal systemHealth Organization
2018
Progressive T1 Shortening of the Dentate Nucleus in Patients With Multiple Sclerosis: Result of Multiple Administrations of Linear Gadolinium Contrast Agents Versus Intrinsic Disease.
Malhotra A, LeSar B, Wu X, Durand D, Das N, Anzai Y, Sanelli P. Progressive T1 Shortening of the Dentate Nucleus in Patients With Multiple Sclerosis: Result of Multiple Administrations of Linear Gadolinium Contrast Agents Versus Intrinsic Disease. American Journal Of Roentgenology 2018, 211: 1099-1105. PMID: 30160975, DOI: 10.2214/ajr.17.19155.Peer-Reviewed Original ResearchConceptsMacrocyclic agent gadobutrolMultiple sclerosisGlobus pallidusDentate nucleusGadolinium-based contrast agentsGadopentetate dimeglumineIntrinsic diseaseContrast injectionMultiple administrationsRelapsing-remitting multiple sclerosisMultiple contrast injectionsSubsequent MRI studiesUnenhanced T1-weighted imagesT1-weighted imagesIntrinsic T1 hyperintensityPons SI ratioContrast agent administrationRetrospective reviewMore dosesT1 hyperintensitySignal intensity ratioContrast agentsGadolinium contrastMRI studiesPatientsSevere Progressive Vision Loss in a Teenager
Alasil T, Malhotra A, Galvin JA. Severe Progressive Vision Loss in a Teenager. JAMA Ophthalmology 2018, 136: 950-951. PMID: 29852027, DOI: 10.1001/jamaophthalmol.2017.6792.Peer-Reviewed Original Research